FollowingacomprehensiveinvestigationbytheChinesejudicialauthorities,GSKChinaInvestmentCo.Ltd(GSKCI)hasbeenidentifiedaccordingtoChineselawtohaveofferedmoneyorpropertytonon-governmentpersonnelinordertoobtainimpropercommercialgains,andhasbeenfoundguiltyofbribingnon-governmentpersonnel.GSKplcfullyacceptsthefactsandevidenceoftheinvestigation,andtheverdictoftheChinesejudicialauthorities.Furthermore,GSKplcsincerelyapologisestotheChinesepatients,doctorsandhospitals,andtotheChineseGovernmentandtheChinesepeople.GSKplcdeeplyregretsthedamagecaused.GSKplcalsoapologisesfortheharmcausedtoindividualswhowereillegallyinvestigatedbyGSKCI.TheillegalactivitiesofGSKCIareaclearbreachofGSKplc’sgovernanceandcomplianceprocedures;andarewhollycontrarytothevaluesandstandardsweexpectfromouremployees.Itisdeeplydisappointingthattheseissueswerenotidentifiedandaddressed.GSKplchasreflecteddeeplyandlearnedfromitsmistakes,hastakenstepstocomprehensivelyrectifytheissuesidentifiedattheoperationsofGSKCI,andmustworkhardtoregainthetrustoftheChinesepeople.Today,GSKplcmakesafurthercommitmenttotheChinesegovernmentandpeoplethatGSKCIwilltaketangibleactionstoestablishitselfasamodelforreforminChina’shealthcareindustry:bycontinuingtoinvestinChinaandsupportingChinasscientificdevelopment;andbyfurtherdevelopmentofinnovativenewmedicinesandvaccinesfordiseasesprevalentinChina.GSKCIwillalsoincreaseaccesstoitsproductsinbothcityandruralareasofChinathroughgreaterexpansionofproductionandthroughpriceflexibility
本文关键词:葛兰,素,史克,总公司,向,中国人民,的,致歉,BV韦德官网
本文来源:BV韦德官网-www.saatsuma.com